BUSM Study: Obesity May Be Impacted by Stress

A new study shows that stress may play a role in the development of obesity. Using experimental models, researchers at Boston University School of Medicine (BUSM) showed that adenosine, a metabolite released when the body is under stress or during an inflammatory response, stops the process of adipogenesis, when adipose (fat) stem cells differentiate into […]

Tagged: ,

Researchers Receive NIH Funding for Genetic Research in Alzheimer’s Disease

Boston University School of Medicine (BUSM) received major funding from the National Institute on Aging (NIA) as part of a national effort to identify rare genetic variants that may protect against and contribute to Alzheimer’s disease risk. The four-year, $3 million grant, “Identifying Risk and Protective Variants for AD Exploring their Significance and Biology” is […]

BUSM’s Robert Stern Testifies Before Senate Committee on Aging

Robert Stern, PhD, professor of neurology, neurosurgery, and anatomy & neurobiology at BU School of Medicine as well as co-founder of BU’s Center for the Study of Traumatic Encephalopathy, testified before the U.S. Senate’s Special Committee on Aging at the June 25 hearing, “State of Play: Brain Injuries and Diseases of Aging.” Stern, who is […]

BUSM Faculty Urged to Participate in AAMC Faculty Engagement Survey

BU School of Medicine is participating in the American Association of Medical Colleges (AAMC) Faculty Forward Engagement Survey to benchmark our faculty members’ engagement levels with peer institutions, and to provide data for us to enhance our efforts to attract, retain, support and advance our faculty. Who is eligible: All full time and part time […]

BUSM Researchers Investigating Ways to Improve Type 2 Diabetes Treatments

A better understanding of how the transcription factor Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma) works is critical to find new ways to improve medications to treat type 2 diabetes. Drugs that activate PPARgamma, called thiazolidinediones (TZDs), have long been regarded as a treatment for type 2 diabetes based on their anti-inflammatory and potent insulin-sensitizing activity. When […]

BUSM Faculty Creates 4 Point Scoring Tool to Predict Bleeding

Many patients require medication to thin blood, and some of these patients also have liver disease. Often warfarin is prescribed for this condition. This presents a challenge for physicians and patients, as the risk of bleeding in patients with liver disease taking warfarin is unknown and has not been studied. BUSM Associate Professor of Medicine […]